Assessment of FIBROSpect II to Detect Hepatic Fibrosis in Chronic Hepatitis C Patients

This prospective study supports the clinical utility of serum markers in detecting fibrosis and validates the performance of FIBROSpect II in a prospective cohort of patients. The high negative predictive value of the test provides a reliable alternative to rule out severe fibrosis.